Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 25.33 USD 4.89% Market Closed
Market Cap: 5.5B USD
Have any thoughts about
Hims & Hers Health Inc?
Write Note

Intrinsic Value

The intrinsic value of one HIMS stock under the Base Case scenario is 12.24 USD. Compared to the current market price of 25.33 USD, Hims & Hers Health Inc is Overvalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HIMS Intrinsic Value
12.24 USD
Overvaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Hims & Hers Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HIMS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HIMS?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Hims & Hers Health Inc

Provide an overview of the primary business activities
of Hims & Hers Health Inc.

What unique competitive advantages
does Hims & Hers Health Inc hold over its rivals?

What risks and challenges
does Hims & Hers Health Inc face in the near future?

Has there been any significant insider trading activity
in Hims & Hers Health Inc recently?

Summarize the latest earnings call
of Hims & Hers Health Inc.

What significant events have occurred
in Hims & Hers Health Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hims & Hers Health Inc.

Provide P/S
for Hims & Hers Health Inc.

Provide P/E
for Hims & Hers Health Inc.

Provide P/OCF
for Hims & Hers Health Inc.

Provide P/FCFE
for Hims & Hers Health Inc.

Provide P/B
for Hims & Hers Health Inc.

Provide EV/S
for Hims & Hers Health Inc.

Provide EV/GP
for Hims & Hers Health Inc.

Provide EV/EBITDA
for Hims & Hers Health Inc.

Provide EV/EBIT
for Hims & Hers Health Inc.

Provide EV/OCF
for Hims & Hers Health Inc.

Provide EV/FCFF
for Hims & Hers Health Inc.

Provide EV/IC
for Hims & Hers Health Inc.

Show me price targets
for Hims & Hers Health Inc made by professional analysts.

What are the Revenue projections
for Hims & Hers Health Inc?

How accurate were the past Revenue estimates
for Hims & Hers Health Inc?

What are the Net Income projections
for Hims & Hers Health Inc?

How accurate were the past Net Income estimates
for Hims & Hers Health Inc?

What are the EPS projections
for Hims & Hers Health Inc?

How accurate were the past EPS estimates
for Hims & Hers Health Inc?

What are the EBIT projections
for Hims & Hers Health Inc?

How accurate were the past EBIT estimates
for Hims & Hers Health Inc?

Compare the revenue forecasts
for Hims & Hers Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hims & Hers Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hims & Hers Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hims & Hers Health Inc compared to its peers.

Compare the P/E ratios
of Hims & Hers Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Hims & Hers Health Inc with its peers.

Analyze the financial leverage
of Hims & Hers Health Inc compared to its main competitors.

Show all profitability ratios
for Hims & Hers Health Inc.

Provide ROE
for Hims & Hers Health Inc.

Provide ROA
for Hims & Hers Health Inc.

Provide ROIC
for Hims & Hers Health Inc.

Provide ROCE
for Hims & Hers Health Inc.

Provide Gross Margin
for Hims & Hers Health Inc.

Provide Operating Margin
for Hims & Hers Health Inc.

Provide Net Margin
for Hims & Hers Health Inc.

Provide FCF Margin
for Hims & Hers Health Inc.

Show all solvency ratios
for Hims & Hers Health Inc.

Provide D/E Ratio
for Hims & Hers Health Inc.

Provide D/A Ratio
for Hims & Hers Health Inc.

Provide Interest Coverage Ratio
for Hims & Hers Health Inc.

Provide Altman Z-Score Ratio
for Hims & Hers Health Inc.

Provide Quick Ratio
for Hims & Hers Health Inc.

Provide Current Ratio
for Hims & Hers Health Inc.

Provide Cash Ratio
for Hims & Hers Health Inc.

What is the historical Revenue growth
over the last 5 years for Hims & Hers Health Inc?

What is the historical Net Income growth
over the last 5 years for Hims & Hers Health Inc?

What is the current Free Cash Flow
of Hims & Hers Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hims & Hers Health Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hims & Hers Health Inc

Current Assets 326.4m
Cash & Short-Term Investments 254.1m
Receivables 4.6m
Other Current Assets 67.7m
Non-Current Assets 275.9m
PP&E 63m
Intangibles 157.5m
Other Non-Current Assets 55.3m
Current Liabilities 152.6m
Accounts Payable 75.4m
Accrued Liabilities 41.6m
Other Current Liabilities 35.6m
Non-Current Liabilities 9.6m
Other Non-Current Liabilities 9.6m
Efficiency

Earnings Waterfall
Hims & Hers Health Inc

Revenue
1.2B USD
Cost of Revenue
-234.3m USD
Gross Profit
1B USD
Operating Expenses
-962.8m USD
Operating Income
44.9m USD
Other Expenses
56.4m USD
Net Income
101.3m USD

Free Cash Flow Analysis
Hims & Hers Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Hims & Hers delivered a remarkable 77% year-over-year sales growth, surpassing $400 million in revenue for the third quarter. Adjusted EBITDA reached $51.1 million, reflecting a 13% margin. The company added over 180,000 new subscribers, totaling over 2 million. It anticipates Q4 revenues between $465 million and $470 million, representing a nearly 91% increase year-over-year. For the full year, expected sales range from $1.46 billion to $1.465 billion, a 67% increase. Moving forward, Hims & Hers plans significant capital investments to improve service capabilities and maximize customer retention through personalized solutions across multiple specialties.

What is Earnings Call?
Fundamental Scores

HIMS Profitability Score
Profitability Due Diligence

Hims & Hers Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROIC
50/100
Profitability
Score

Hims & Hers Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

HIMS Solvency Score
Solvency Due Diligence

Hims & Hers Health Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
75/100
Solvency
Score

Hims & Hers Health Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HIMS Price Targets Summary
Hims & Hers Health Inc

Wall Street analysts forecast HIMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIMS is 25.74 USD with a low forecast of 18.18 USD and a high forecast of 33.6 USD.

Lowest
Price Target
18.18 USD
28% Downside
Average
Price Target
25.74 USD
2% Upside
Highest
Price Target
33.6 USD
33% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HIMS?

Click here to dive deeper.

Dividends

Hims & Hers Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HIMS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HIMS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

HIMS News

Other Videos

Profile

Hims & Hers Health Inc Logo
Hims & Hers Health Inc

Country

United States of America

Industry

Health Care

Market Cap

5.5B USD

Dividend Yield

0%

Description

Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 398 full-time employees. The company went IPO on 2019-09-09. The firm has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The firm has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. The company offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The firm's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.

Contact

CALIFORNIA
San Francisco
2269 Chestnut St, #523
+14158510195.0
www.forhims.com

IPO

2019-09-09

Employees

398

Officers

Co-Founder, Chairman & CEO
Mr. Andrew Dudum
Chief Financial Officer
Mr. Yemi Okupe
Chief Operating Officer
Ms. Melissa Baird
Chief Legal Officer & Corporate Secretary
Ms. Soleil Teubner Boughton
Chief Medical Officer, Member of Medical Advisory Board & Director
Dr. Patrick Carroll M.D.
Chief Commercial Officer
Mr. Mike Chi
Show More
Senior VP, Controller & Principal Accounting Officer
Ms. Irene A. Becklund
Chief Communications Officer
Ms. Khobi Brooklyn
Senior Vice President of Human Resources
Ms. Amee Parekh
Senior VP & Member of Medical Advisory Board
Dr. Peter Stahl M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one HIMS stock?

The intrinsic value of one HIMS stock under the Base Case scenario is 12.24 USD.

Is HIMS stock undervalued or overvalued?

Compared to the current market price of 25.33 USD, Hims & Hers Health Inc is Overvalued by 52%.

Back to Top